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Abstract: The objective of this study was to establish a correlation between histopathology and 
radiological characteristics as well as location of brain stem tumors. Results of therapy were also 
analysed in relation to the radiological characteristics. Forty four patients were evaluated from a 
clinical and neuroradiological viewpoint (CT and MRI). In 14 of them we ruled out a surgical therapy. 
However 30 patients with an age ranging from 4 to 62 years were operated on with complete resection 
in most cases. We attempted to correlate histopathology with the radiological pattern and location of 
the tumours. The clinical presentation was as follows: symptoms of cranial nerve involvement in 21, 
cerebellar symptoms in 18 and pyramidal syndrome in 13.  Histopathology was obtained by means of 
stereotactic biopsy in 4 cases and by means of surgical specimens in 26 cases. Tumors were well 
defined (focal) in 16 cases and diffuse in 14. Complete removal was achieved in 18 cases and partial in 
8. Intraoperative neurophysiologic monitoring was carried out in all cases. Most malignant tumors tend 
to locate in the pons and to be radiologically diffuse. Conversely, benign tumors use to be focal and to 
locate in the midbrain, medulla and cervicomedullary junction. There is a good correlation between 
histopathology and the anatomical location of brain-stem tumors. An adequate selection of cases for 
surgery based on clinicoradiological criteria and the use of intraoperative neurophysiologic monitoring 
are of help to improve prognosis after surgery in brain stem tumors. 
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INTRODUCTION 
 
  The diagnosis and management of brain stem 
tumors has improved markedly in the last 30 years 
owing to the advances in the neuroradiological 
techniques, intraoperative neurophysiology and surgical 
techniques aided by ultrasonic aspirator, lasser devices 
and microscopy. These advances have made it possible 
to remove tumors considered before inoperable. 
  In the past brain-stem tumors were regarded as a 
gloomy chapter in neurosurgery
[9].  The first surgical 
series appeared in the 60s
[6,53,58].  In 1969, on the basis 
of their location and difficult approach, Matson defined 
these tumors as malignant regardless of 
histopathology
[53].  Before the use of CT all of these 
tumors were seen as a homogeneous group. Only 
anecdotal reports of successful surgery and long 
survival were published
[58]. 
  Brain-stem tumors and brain-stem gliomas are 
terms used indistinctly because gliomas are the most 
frequent tumor type at this location. In pediatric wards 
gliomas constitute 90% of the cases
[24,28], however 
many other types of tumors may appear in the brain-
stem: meningiomas, lymphomas, metastasis, arachnoid 
cysts, abscesses and cavernomas
[34]. Other reported 
tumors are hemangioblastomas
[40], epidermoid cysts
[56] 
and lipomas
[15,62].  Favorable outcomes after surgery 
became to appear in the 80s
[6,25,28,41,63]. 
  Despite the heterogeneous spectrum of the brain-
stem tumors histopathology is verified at most in 58% 
of cases
[47].  This may be due to the small quantity of 
tissue from biopsies or to the inherent difficulty to 
perform them. For these reasons neuroradiology has a 
very important role in the initial assessment of the 
lesions. 
  From 1980 onwards important advances emerged 
in the field of neuroradiology, neurophysiology and 
neurosurgical techniques with many attempts to classify 
these tumors
[15,23,25,27,28,30,40] and based on CT and MRI 
techniques The main purpose of classifying tumors was 
to identify those amenable to surgical removal. The use 
of intraoperative neurophysiologic monitoring (sensory 
and motor evoked potentials) provides information in 
real time on the integrity of brain-stem throughout the 
surgical intervention
[20]. The incorporation of modern 
devices such as surgical microscopy, bayonet OnLine J. Biol. Sci., 7 (2): 72-79, 2007 
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plaques
[26], contact lasser (Nd-YAG)
[46] and ultrasonic 
aspirator (CUSA)
[19,42] greatly contributed to refine the 
surgical techniques.  
  There are a few reports pointing to a relationship 
between location and histopathology and prognosis in 
brain stem tumors. In the experience of Albright et al. 
the prognosis of midbrain tumors was excellent
[5].  In 
the cervicomedullary junction the reported tumours are 
mostly low-grade gliomas
[24,25].  Gomez-Gosalvez et al. 
reported that all of the 8 tectal tumors were benign
[38]. 
  The aim of our study is to verify the hypothesis 
that the location and radiological aspect of tumors 
correlates to histopathology and prognosis.  
 
PATIENTS AND METHODS 
 
  A total of 44 consecutive cases with brain-stem 
tumor were initially included in the study but 
histopathology was possible in 30. The mean age was 
22 years (range: 4-62 y). All of them underwent CT and 
MRI of the brain and were followed up. The duration of 
clinical symptoms before diagnosis ranged from 45 
days to 7 years. In 14 cases it was not possible to get 
histopathological verification. In the remainder 
histopathology was obtained by means of biopsy in four 
cases and by the surgical specimen in twenty six. From 
a neuroradiological viewpoint we evaluated the focal or 
diffuse aspect of the tumours, the exophytic component 
and location: mesencephalic, diffuse in the whole brain-
stem (midbrain-pontine-medullary), pontine, pontine-
medullary, medullary and cervico-medullary. We also 
studied the correlation to the symptoms leading to the 
performance of CT and MRI 
  The surgical intervention was made with the 
patients semiincorporated and under cardiorespiratory 
monitoring. Neurophysiologic monitoring included 
Somatosensory Evoked Potentials and auditive 
troncular potentials throughout the surgical 
intervention. We used microsurgical technique and 
Lasser CO2. 
  After surgery the patients were followed-up for 
variable periods of time with postoperative CT and 
MRI (range: 6 months-two years). 
 
RESULTS AND DISCUSSION 
 
  In table 1 are reported the clinical symptoms 
leading to the diagnosis according to the anatomic 
location of the tumors in the 30 cases with 
histopathology. There were 18 men and 12 women. The 
most frequent initial manifestations were: cranial nerve 
paresis in 21, cerebellar symptoms in 18 and pyramidal 
syndrome in 13. Histopathology was established by 
stereotactic biopsy in 4 cases and by examination of 
surgical specimens in 26. 
  In table 1 are also reported the radiological aspect, 
location and histopathology. CT clearly demonstrated 
the tumor in 24 cases by showing hypodense areas, 
contrast enhancement and cystic or necrotic areas. In 
case 13 (low-grade astrocytoma) CT was unable to 
detect the lesion although it met on evidence 
triventricular hydrocephalus.  In case 9 (low-grade 
astrocytoma) CT was negative and it also occurred in 
cases 12 (pontine malignant neurofibroma), 7 
(Meduloblastoma), 15 (lipoma of the medulla) and 16 
(ependymoma of the cervicomedullary junction in 
which only the solid component was seen in the 
medulla). 
  MRI was superior to show the lesions and to 
establish location. The radiological aspect was better 
distinguished (focal, diffuse and exophytic component) 
as well. According to table 1 only the pons was the site 
of development of malignant tumors. 
  CT-guided satereotactic biopsy was carried out in 4 
cases. In 3 of them surgery was dismissed because of 
the malignancy of lesions in the pons; instead we chose 
radiotherapy. In the remaining cases a surgical 
approach was performed based on the benign aspect, 
exophytic or subependymal growth or cystic areas.  
  Complete macroscopic resection was achieved in 
18 cases and partial in 8. A ventriculoperitoneal shunt 
was needed in a case of mesencephalic low-grade 
astrocytoma. The reasons for partial resection were 
malignancy and diffuse spreading of the tumor in 7 
cases and perioperative cardiorespiratory disturbances 
in one case. 
  Perioperative neurophysiologic assessment was 
carried out in all cases and included Somatosensory 
evoked potentials and  auditive troncular potentials; 
occasionally we used blink reflex and visual evoked 
potentials. Neurophysiologic monitoring allowed us to 
observe functional improvement after opening pial 
tissues in 9 cases (pons and medulla tumors). In one 
case surgery was stopped due to serious alterations in 
neurophysiologic monitoring. 
  Surgery was initially well tolerated. In case 6 
(anaplastic astrocytoma) surgery complicated with 
intracavitary hemorrhage, coma and death after 3 
months of surgery. We saw transient sequelae in four 
patients: cranial nerve dysfunction, ataxia, vertical and 
horizontal gaze dysfunction and incoercible vomiting 
(subependymoma of IV ventricle). All of these 
symptoms resolved completely after a maximum period 
of 6 months.  
  The 4 non-operated patients with malignant lesions 
survive   less  than  one  year (3,  5,  6  and  8   months),OnLine J. Biol. Sci., 7 (2): 72-79, 2007 
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Table 1: Location, radiological aspect, histopathology and clinical symptoms in our series of 30 cases with brain-stem tumour. 
       Clinical  symptoms 
Case  Location of tumour  Border type  Histopathology  leading to diagnosis 
1  Pontine-medullary  Well defined, with  Mixed-grade astrocytoma  Cerebellar ataxia, cranial nerve paresis. 
    exophytic component  with low mitotic index.   
2  Pontine-medullary  Well defined, with  Mixed-grade astrocytoma  Cerebellar ataxia, cranial nerve 
    exophytic component  with low mitotic index  paresis, intracranial hypertension. 
3 Pons  Diffuse  Glioblastoma  Cerebellar ataxia, cranial nerve paresia, 
       pyramidal  syndrome 
4 Pons  Diffuse  Glioblastoma  Cerebellar ataxia, cranial nerve 
        paresia,  pyramidal syndrome 
5 Pontine-medullary  Diffuse  Low-grade  Astrocytoma   Cerebellar ataxia, cranial nerve paresis. 
6  Pontine-medullary  Diffuse, with exophytic Anaplastic  Astrocytoma    Cerebellar ataxia, cranial nerve paresis, 
    component    intracranial hypertension, cervical dystonia 
7  Pons  Diffuse, with exophytic  Meduloblastoma  Cerebellar ataxia, cranial nerve 
    component    paresis, intracranial hypertension, 
       pyramidal  syndrome 
8  Medulla  Well defined  Low-grade Astrocytoma  Hemisensory syndrome, hypotonia. 
9 Cervicomedullary  Well  defined  Low-grade Astrocytoma  Hemisensory syndrome 
10  Pons  Diffuse, with exophytic  Glioblastoma  Cerebellar ataxia, cranial nerve 
   component    paresis,  pyramidal  syndrome 
11  Pontine-medullary  Well defined, with  Low-grade subependimoma  Cerebellar ataxia, cranial nerve 
    exophytic component    paresis, intracranial hypertension 
12  Pons  Well defined  Malignant Neurofibroma  Cranial nerve paresia 
13  Midbrain  Well defined  Low-grade Astrocytoma  Unsteadiness of gait, diplopia 
14  Pons  Diffuse, with exophytic  Metastasis from lung cancer  Cerebellar ataxia, cranial nerve 
    component    paresis, intracranial hypertension 
15 Cervicomedullary  Well  defined  Lipoma  Pyramidal syndrome with spasticity 
       and  tetraparesis 
16  Cervicomedullary  Well defined, with  Low-grade ependimoma  Pyramidal syndrome with 
    exophytic component    spasticity and tetraparesis 
17  Midbrain and pons  Well defined  Low-grade Astrocytoma   Pyramidal syndrome, intracranial 
        hypertension, Unsteadiness of gait 
18  Pontine-medullary  Well defined, with  Low-grade Astrocytoma   Cranial nerve paresis 
   exophytic  component 
19  Pons, fourth ventricle  Diffuse, with  Meduloblastoma  Cerebellar ataxia, cranial nerve 
    exophytic component    paresis, intracranial hypertension 
20 Midbrain,  Diffuse  Low-grade  Astrocytoma   Cerebellar ataxia, cranial nerve 
 Pontine-medullary     paresis 
21  Pontine-medullary  Well defined, with  Low-grade Astrocytoma   Cerebellar ataxia, cranial nerve 
    exophytic component    paresis, intracranial hypertension 
22  Midbrain and thalami  Well defined  Low-grade Astrocytoma   Cerebellar ataxia, pyramidal 
       syndrome 
23  Midbrain,  Diffuse  Low-grade Astrocytoma   Pyramidal syndrome 
 Pontine-medullary 
24  Pontine-medullary  Well defined, with  Low-grade Astrocytoma   Pyramidal syndrome, cranial nerve 
   exophytic  component   paresis 
25  Diffuse brain stem  Diffuse, with  Glioblastoma  Pyramidal syndrome, intracranial 
  and cerebellum  exophytic component    hypertension, cranial nerve paresis 
26  Diffuse brain stem  Diffuse, with  Anaplastic Astrocytoma   Cranial nerve paresis 
  and cerebellum  c exophytic omponent 
27  Diffuse brain stem  Diffuse  Low-grade Astrocytoma   Cerebellar ataxia, cranial nerve 
 and  cerebellum      paresis 
28  Pontine medullary  Well defined, with  Low-grade Astrocytoma   Cerebellar ataxia, cranial nerve 
    exophytic component    paresis, intracranial hypertension 
29  cervico-medullary  Well defined  Low-grade Astrocytoma   Pyramidal syndrome with 
  junction      spasticity and tetraparesis 
30  cervico-medullary  Diffuse, with exophytic  Anaplastic Astrocytoma  Pyramidal syndrome with 
  junction and cerebellum  component    spasticity and tetraparesis, cerebellar 
        ataxia, cranial nerve paresis OnLine J. Biol. Sci., 7 (2): 72-79, 2007 
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(b)
 
 
Fig. 1(a-b): Schematic representation of sites in which tumours locate in the brain-stem. Malignat tumours are 
located in the areas marked in red and the benign ones in areas marked in blue 
 
   
   (a)  (b) 
Fig. 2: (a): Sagittal T1-weighted showing a gadolinium-enhanced lesion in the medulla in the case 8 (low-grade 
astrocytoma). (b): T2-weighted MRI showing a focal mass in the medulla and which was a low-grade 
astrocytoma (case 8). 
 
whereas the 7 that were operated on survive from 5 to 
16 months. The cause of death was the recurrence of 
the tumor. 
  Brain-stem tumors encompass an array of 
heterogeneous lesions that may appear at any age. In 
our series we saw cases aged between 4 and 62 years. 
Gliomas are the most frequent tumoral lesions in the 
brain-stem with special tendency to present in 
chilhood
[14,52,11,4]. Like in other studies, we did not see 
predilection by sex
[14,52,11,4]. OnLine J. Biol. Sci., 7 (2): 72-79, 2007 
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  The mean duration of symptoms before diagnosis 
does matter greatly. Relationship between duration of 
sympton and prognosis has been previously 
encountered
[51,49,11,35,33,12], with benign tumors having   
period of symptoms longer than 6 months before 
diagnosis
[11].  Guillamo et al. concluded that in adults 
duration of symptoms longer than 3 months in brain 
stem gliomas is a good pronostic indicator
[39].   In our 
series the duration of symptoms was shorter than 5 
months in malignant tumors.  
  Due to the high concentration of axons in brain-
stem structures the symptoms of tumors at this location 
can appear before these are detected by neuroradiologic 
techniques
[21,51]. Our patients presented frequently with 
cranial nerve dysfunction, cerebellar symptoms and 
pyramidal-tract symptoms. These symptoms were also 
the most frequently found in other series
[8,55,66]. In ten 
cases (30%) we observed symptoms of intracranial 
hypertension. Similar proportion (20%) had intracranial 
hypertension in the series of Badhe. We saw that 
malignant tumors located in the pons and had shorter 
symptom duration until diagnosis. 
  Brain-stem tumours account in one of every 5 
cases of brain tumors in children and less frequently in 
adults with gliomas being the most 
common
[5,11,12,33,51,59]. The broad spectrum of 
histopathology appeared in our series was also present 
in other studies
[15,40,56,62,24,48]. The proportion 
malignant/benign tumors was 36.7/63.3% in our series 
and this proportion was similar to that found by, Tomita 
et al.
[64]. Among malignant tumors the most frequent 
were high-grade astrocytomas as it was observed by 
other authors
[33,50,51]. 
  As it was expected MRI was superior to CT to 
detect brain-stem tumors. CT only detected 62.5% of 
the lesions in comparison to 100% detected by MRI. 
Given the high diagnostic accuracy of MRI in brain-
stem gliomas, biopsy prior surgery is discouraged in 
many centres
[43,13,31,67,38,5], especially in diffuse and 
infiltrative gliomas
[5,18]. This does not mean that MRI is 
substitutive of histopathology
[7,8]. Biopsy and/or 
surgery is especially recommended in tumors with well-
defined borders, exophytic component
[3,16,37] and those 
cystic and of cervicomedullary location because they 
are virtually benign
[29].  
  On the basis of CT and MRI characteristics there 
are several modes of classifying brain-stem tumors to 
identify those amenable to surgery (44).  The first 
systems were based on CT images in the 80s
[23,63]. Once 
MRI emerged other systems of classification appeared 
in the 90s
[2,10,17] with the aspect of the epicentre (focal 
or diffuse) being the main criterion. The more complex 
systems classify tumors by location, aspect focal or 
diffuse, presence/absence of hydrocephalus and growth 
pattern
[44]. For classification purposes we use the 
following criteria: location, aspect of the tumor border 
(well defined or diffuse) and the presence/absence of 
exophytic component.  
  Albright and coworkers determined the prognostic 
importance of tumor location and that 100% of 
midbrain tumors had excellent prognosis
[5]. Another 
report showed that tectal tumors are benign
[38]. 
Cervicomedullary tumors are mostly low-grade 
tumors
[24,45]. 
  We found that pontine and pontine-medullary 
tumors are mostly malignant, (10/16) and especially 
those purely pontine. The bad prognosis of pontine 
tumors has been also found in other studies
[5,11,47]. A 
survival of only 18% was achieved at 3-5 year follow-
up
[5].  
  The radiological tumoral border (aspect focal or 
diffuse) was important in our study. Most lesions 
(93.75%) with well-defined border were benign. In 
turn, lesions with diffuse borders were mostly 
malignant (71.4%). According to Albright et al. focal 
lesions had favorable outcome with 85% survival rate at 
3-5 years
[5]. Focal lesions are usually low-grade 
tumors
[24,1,22,65,61].  However, some malignant lesions 
such as primitive neuroectodermal tumors may present 
like benign
[11]. Diffuse lesions are associated with poor 
prognosis with a survival at most of 20% at 3-5 years
[5]. 
  Behnke regarded the pontine tumors with 
hypertrophyc aspect as malignant in general
[11]. In 
childhood diffuse lesions are usually malignant
[61].  
Guillamo et al. found that in young adults (<40 years). 
In this series diffuse pontine-medullary tumors were 
low-grade gliomas, but in older patients these are 
mostly malignant
[39]. 
  In our series the exophytic component was equally 
represented in malignant and benign tumors. This 
component point to low-grade gliomas when appear in 
children
[45]. There may be cases difficult to classify 
according to neuroimaging techniques and these may 
benefit from stereotactic biopsy. For example some 
tumors of diffuse aspect in neurofibromatosis may be 
benign and may benefit from surgery
[54]. In addition 
biopsy could make it possible to evacuate cystic 
formations as it occurred in two of 4 cases with pontine 
lesions. However stereotactic biopsy of brain-stem 
carries serious risks. We saw tachiarritmia in two of 4 
cases of pontine biopsy with spontaneous recovery. The 
use of intraoperative evoked potentials is mandatory. 
We observed dramatic improvement in conduction after 
decompression in two cases.  
  In our series 26 patients underwent surgery with 
total resection in 18 and partial in 8. In the series of OnLine J. Biol. Sci., 7 (2): 72-79, 2007 
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Pierre-Kahn  et al. with  75 children operated from 
brain-stem tumors the proportion of partial resection 
was 44,5%, subtotal in 32% and total in 23,5%
[57]. 
Postoperative morbidity should not surpass 20%
[57]. In 
our series morbidity was 30% (9/26) with favorable 
outcome and this may be due to the higher proportion 
of total resection. 
  In conclusion, a broad array of tumors may appear 
in the brain-stem with gliomas being the most frequent 
ones. A prognosis can be established according to the 
location and radiological aspect. Benign tumors use to 
be focal and to locate in the midbrain, medulla and 
cervico-medullary junction. Conversely, malignant 
lesions are mostly diffuse in aspect and tend to locate in 
the pons. The location and aspect of brain-stem tumors 
are of help in the surgical approach of the patients. 
 
REFERENCES 
 
1.  Abbott,  R.,  T.  Shiminski-Maher,  J.H. Wisoff, 
F.J. Epstein, 1991-92. Intrinsic tumors of the 
medulla: surgical complications. Pediatr 
Neurosurg, 17: 239-44. 
2.  Albright, A.L., 1996. Brain stem gliomas, in 
Youmans J. (4th Edn.) Neurological Surgery. 
Philadelphia WB Saunders Co, pp: 2603-2611. 
3. Albright, A.L., 1993. Tumors of the pons. 
Neurosurg Clin. N. Am., 4: 529-36. 
4.  Albright, A.L., R.A. Price and A.N. Guthkelch, 
1983.  Brain stem gliomas of children. A 
clinicopathological study. Cancer, 52: 2313-2319. 
5.  Albright,  A.L.,  R.J.  Packer,  R.  Zimmerman, 
L.B. Rorke, J. Boyett and G.D. Hammond, 1993. 
Magnetic resonance scans should replace biopsies 
for the diagnosis of diffuse brain stem gliomas: A 
report from the Childrens Cancer Group. 
Neurosurgery, 33: 1026-1029. 
6.  Alvisi, C., M. Cerisoli and M.E. Maccheroni, 1985. 
Long-term results of surgically treated brainstem 
gliomas. Acta Neurochir (Wien), 76: 12-17. 
7.  Artigas,  J.,  R.  Ferszt,  M.  Brock, E. Kazner and 
J. Cervos-Navarro, 1998. The relevance of 
pathological diagnosis for therapy and outcome of 
brain stem gliomas. Acta Neurochir Suppl (Wien), 
42: 166-169. 
8.  Badhe, P.B., P.P. Chauhan and N.K. Mehta, 2004. 
Brainstem gliomas: a clinicopathological study of 
45 cases with p53 immunohistochemistry. Ind. J. 
Cancer, 41: 170-174. 
9.  Bailey, P., D.N. Buchanan and P. Bucy, 1939. 
Intracranial Tumors of Infancy and Childhood. 
Chicago, University of Chicago Pres, pp: 188. 
10. Barkovich, A.J., J. Krischer, L.E. Kun, R. Packer, 
R.A.  Zimmerman,  C.R.  Freeman, W.M.  Wara, 
L. Albright, J.C. Allen and H.J. Hoffman, 1990-
1991. Brain stem gliomas: a classification system 
based on magnetic resonance imaging. Pediatr 
Neurosurgery, 16: 73-83. 
11.  Behnke,  J.,  H.J.    Christen,     W.    Bruck    and 
E. Markakis, 1997. Intra-axial endophytic tumors 
in the pons and/or medulla oblongata. I. 
Symptoms, neuroradiological findings and 
histopathology in 30 children. Childs Nerv Syst., 
13: 122-134. 
12.  Behnke,   J.,    H.J.    Christen,    K.    Mursch   and 
E. Markakis, 1999. Intra-axial endophytic tumors 
in the pons and/or medulla oblongata. II. 
Intraoperative findings, postoperative results and 2-
year follow up in 25 children. Childs Nerv Syst., 
13: 135-146. 
13.  Benesch,   M.,  H.   Lackner, A. Moser, R. Kerbl, 
W.   Schwinger,   R.    Oberbauer,   H.G.     Eder, 
R. Mayer, K. Wiegele and C. Urban, 2001. 
Outcome and long-term side effects after 
synchronous radiochemotherapy for childhood 
brain     stem    gliomas.    Pediatr      Neurosurgery, 
35: 173-180. 
14.  Berger,   M.S.,   M.S.    Edwards,  D. LaMasters, 
R.L. Davis and C.B. Wilson, 1983. Pediatric brain 
stem tumors: Radiographic, Pathological and 
Clinical Correlations. Neurosurgery, 12: 298-302. 
15.  Bilaniuk,   L.T.,   R.A.   Zimmerman, P. Littman, 
E. Gallo, L.B. Rorke, D.A. Bruce and L. Schut, 
1980. Computed tomography of brain stem gliomas 
in children. Radiol., 134: 89-95. 
16.  Chico-Ponce de Leon, F., M. Perezpena-Diazconti, 
E. Castro-Sierra, F.J. Guerrero-Jazo, L.F. Gordillo-
Dominguez,   R. Gutierrez-Guerra, T. Salamanca, 
G.   Sosa-Sainz,   B.L.   Santana-Montero      and 
A. DeMontesinos-Sampedro, 2003. 
Stereotactically-guided  biopsies of brainstem 
tumors. Childs Nerv Syst., 19: 305-310. 
17. Choux, M., G. Lena and L. Do, 2000. Brainstem 
tumors, in Choux, M., C. Di Rocco and A. Hockley 
(Eds.): Pediatric Neurosurgery. New York: 
Churchill Livingstone, pp: 471-491. 
18. Constantini, S. and F. Epstein, 1996. Surgical 
indication and technical considerations in the 
management of benign brain stem gliomas. J. 
Neurooncol., 28: 193-205. 
19. Constantini, S. and F. Epstein, 1996. Ultrasonic 
dissection in neurosurgery. In Wilkins, R.H. and 
S.S. Rengachary (Eds.): Neurosurgery, (2nd Edn.), 
New York: McGrawHill, 1: 607-608. OnLine J. Biol. Sci., 7 (2): 72-79, 2007 
 
  78
20.  Deletis, V., F. Sala and N. Morotoa, 2000. 
Intraoperative neurophysiological monitoring and 
mapping during brain stem surgery: A modern 
approach.  Operative Techniques in Neurosurgery, 
3: 109-113. 
21. Donaldson, S.S., F. Laningham and P.G. Fisher, 
2006. Advances toward an understanding of 
brainstem gliomas. J. Clin. Oncol., 24: 1266-1272. 
22.  Edwards,   M.S.,   W.M.   Wara,   R.C.   Urtasun, 
M.  Prados,   V.A. Levin, D. Fulton, C.B. Wilson, 
J. Hannigan and P. Silver, 1988.  Hyperfractionated 
radiation therapy for brain-stem glioma: A phase I-
II trial. J. Neurosurgery, 70: 691-700. 
23.  Epstein, F., 1985. A staging system for brain stem 
gliomas. Cancer, 56: 1804-1806. 
24. Epstein, F.J. and J.P. Farmer, 1993. Brain-stem 
glioma   growth     patterns     J.      Neurosurgery, 
78: 408-412. 
25. Epstein, F. and E.L. McCleary, 1986. Intrinsic 
brain-stem tumors of childhood: Surgical 
indications. J. Neurosurgery, 64: 11-15. 
26. Epstein, F.J. and M. Ozek, 1993. The plated 
bayonet: a new instrument to facilitate surgery for 
intra-axial neoplasms of the spinal cord and brain 
stem.    Technical      note.     J.      Neurosurgery, 
78: 505-507. 
27.  Epstein, F. and J. Wisoff, 1987. Intra-axial tumors 
of the  cervicomedullary junction. J. Neurosurgery, 
67: 483-487. 
28.  Epstein, F. and J.H. Wisoff, 1988. Intrinsic 
brainstem tumors in childhood: Surgical 
indications. J. Neurooncol., 6: 309-317. 
29.  Epstein, F. and J. Wisoff, 1989. Brainstem tumors 
in childhood: Surgical indications. In: McLaurin 
RL, Schut L, Venes JL, et al. (Eds) Pediatric 
neurosurgery. Surgery of the developing nervous 
system. Saunders Philadelphia, pp: 357-365. 
30. Fahlbusch, R., C. Strauss, W. Huk, G. Rockelein, 
D. Kompf and K.W. Ruprecht, 1990.  Surgical 
removal of pontomesencephalic cavernous 
hemangiomas. Neurosurgery, 26: 449-456. 
31.  Farmer,   J.P.,   J.L.   Montes,      C.R.   Freeman, 
K.   Meagher-Villemure,    M.C.   Bond     and 
A.M. O’Gorman, 2001. Brainstem Gliomas. A 10-
year   institutional   review.   Pediatr Neurosurgery, 
34: 206-214. 
32.  Fischbein, N.J., M.D. Prados, W. Wara, C. Russo, 
M.S. Edwards and A.J. Barkovich, 1996. 
Radiologic classification of brain stem tumors: 
Correlation of magnetic resonance imaging 
appearance with clinical outcome. Pediatr 
Neurosurgery, 24: 9-23. 
33. Fisher,   P.G.,   S.N.  Breiter,    B.S.    Carson, 
M.D.   Wharam, J.A. Williams, J.D. Weingart, 
D.R.   Foer,   P.T.   Goldthwaite,  T.   Tihan  and 
P.C.  Burger, 2000. A clinicopathologic reappraisal 
of brain stem tumor classification. Identification of 
pilocystic astrocytoma and fibrillary astrocytoma 
as distinct entities. Cancer, 89: 1569-1576. 
34.  Frank,   F., A.P. Fabrizi, R. Frank-Ricci, G. Gaist, 
R. Sedan and J.C. Peragut, 1988. Stereotactic 
biopsy and treatment of brain stem lesions: 
Combined study of 33 cases 
(Bologna-Marseille). Acta Neurochir Suppl 
(Wien), 42: 177-181. 
35. Freeman, C.R. and J.P. Farmer, 1998. Pediatric 
brain stem gliomas: A review. 
Int. J. Radiat. Oncol. Biol. Phys., 40: 265-271. 
36.  Gomez-Gosalvez,  F.A.,   F.   Menor,   A. Morant, 
F.   Clemente,   P.    Escriva,   J.    Carbonell   and 
F.  Mulas, 2001. Tectal tumours in paediatrics. A 
review of eight patients. Rev. Neurol., 33: 605-611. 
37. Goncalves-Ferreira, A.J., M. Herculano-Carvalho 
and J. Pimentel, 2003. Stereotactic biopsies of 
focal   brainstem    lesions.    Surgery     Neurol., 
60: 311-320. 
38. Guillamo, J.S., F. Doz and J.Y. Delattre, 2001. 
Brain    stem    gliomas.   Curr.   Opin.    Neurol., 
14: 711-715. 
39.  Guillamo,   J.S.,   A.   Monjour,   L.    Taillandier, 
B. Devaux, P. Varlet, C. Haie-Meder, G.L. Defer, 
P.   Maison,   J.J.   Mazeron,   P.    Cornu    and 
J.Y. Delattre, 2001. Association des Neuro-
Oncologues d’Expression Francaise (ANOCEF). 
Brainstem gliomas in adults: Prognostic factors and 
classification. Brain, 124: 2528-2539. 
40. Heffez, D.S., S.J. Zinreich and D.M. Long, 1990. 
Surgical resection of intrinsic brain stem lesions: 
An overview. Neurosurgery, 27: 789-797. 
41.  Hoffman, H.J., L. Becker and M.A. Craven, 1980. 
A clinically and pathologically distinct group of 
benign    brain     stem   gliomas.    Neurosurgery, 
7: 243-248. 
42.  Jallo, G.I, 2001. CUSA Excel ultrasonic aspiration 
system.  Neurosurgery, 48: 695-697. 
43. Jallo, G.I., A. Biser-Rohrbaugh and D. Freed, 
2004.   Brainstem   gliomas.   Child.  Nerv. Syst., 
20: 143-153. 
44.  Jallo,   G.I.,   D.   Freed,   C.   Roonprapunt     and 
F.  Epstein, 2003. Current management of 
brainstem gliomas.     Annals   of    Neurosurgery, 
3: 1-17. 
45. Jallo, G., K. Kothbauer and F. Epstein, 2000. 
Surgical management of cervicomedullary and 
dorsally exophytic brain stem tumors.  Operative 
Techniques in Neurosurgery, 3: 131-136. OnLine J. Biol. Sci., 7 (2): 72-79, 2007 
 
  79
46.  Jallo, G.I., K.F. Kothbauer and F.J. Epstein, 2002. 
Contact   laser microsurgery. Child. Nerv. Syst., 
18: 333-336. 
47.  Jenkin,   R.D.,   C.   Boesel,   I.   Ertel, A. Evans, 
R. Hittle, J. Ortega, R. Sposto, W. Wara, C. Wilson 
and J. Anderson et al., 1987. Brain-stem tumors in 
childhood: a prospective randomized trial of 
irradiation with and without adjuvant CCNU, VCR 
and prednisone. A report of the Childrens Cancer 
Study Group. J. Neurosurgery, 76: 227-233. 
48. Kahn, A.P., J.F. Hirsch and M. Vinchon et al., 
1993. Surgical management of brainstem tumor in 
children: results and statistical analysis of 75 cases. 
J. Neurosurgery, 79: 845-852. 
49. Kaplan, A.M., A.L. Albright, R.A. Zimmerman, 
L.B.   Rorke,   H.   Li,  J.M. Boyett, J.L. Finlay, 
W.M. Wara and R.J. Packer, 1996. Brainstem 
gliomas in children. A Children’s Cancer Group 
review  of   119   cases.     Pediatr     Neurosurgery, 
24: 185-192. 
50.  Khatib,   Z.A.,   R.L.   Heideman,   E.H. Kovnar, 
J.A.  Langston,   R.A.   Sanford,   E.C.     Douglas, 
J.   Ochs,   J.J.   Jenkins,   D.L.    Fairclough    and 
C. Greenwald et al., 1994. Predominance of 
pilocytic histology in dorsally exophytic brain stem 
tumors. Pediatr Neurosurgery, 20: 2-10. 
51.  Kornreich,   L.,   M.   Schwarz,   B.    Karmazyn, 
I.J.   Cohen,   A.   Shuper,   S. Michovitz, I. Yaniv, 
E. Fenig and G. Horev, 2005. Role of MRI in the 
management of children with diffuse pontine 
tumors: a study of 15 patients and review of the 
literature. Pediatr Radiol., 35: 872-879. 
52. Littman, P., P. Jarrett, L.T. Bilaniuk, L.B. Rorke, 
R.A. Zimmerman, D.A. Bruce, S.C. Carabell and 
L. Schut, 1980. Pediatric brain stem gliomas. 
Cancer, 45: 2787-2792. 
53.  Matson, D.D., 1969. Tumors of the posterior fosa.  
In: Neurosurgery of Infancy and Childhood. 
Thomas  Springfield, IL,  pp: 469-477. 
54. Milstein,   J.M.,   J.R. Geyer, M.S. Berger and 
W.A. Bleyer, 1989. Favorable prognosis for 
brainstem gliomas in neurofibromatosis. J. 
Neurooncol., 7: 367-371. 
55.  Mursch,   K.,   M.E.   Halatsch,   E. Markakis and 
J. Behnke-Mursch, 2005. Intrinsic brainstem 
tumours in adults: results of microneurosurgical 
treatment of 16 consecutive patients. Br. J. 
Neurosurgery, 19: 128-136. 
 
 
 
 
 
56. Obana, W.G. and C.B. Wilson, 1991. Epidermoid 
cysts of the brain stem. Report of three cases. J. 
Neurosurgery, 74: 123-128. 
57.  Pierre-Kahn,   A.,  J.F.   Hirsch,     M.     Vinchon, 
C. Payan, C. Sainte-Rose, D. Renier, A. Lelouch-
Tubiana and J. Fermanian, 1993. Surgical 
management of brain-stem tumors in children: 
Results and statistical analysis of 75 cases. J. 
Neurosurgery, 79: 845-852. 
58. Pool, J.L., 1969. Gliomas in the region of the 
brainstem. J. Neurosurg, 29: 164. 
59. Ragheb, J. and F. Epstein, 2000. The surgical 
classification and management of brainstem tumors 
in children.  Review. Int. Pediatrics, 15: 15-20. 
60. Robertson,   P.L.,   J.C.   Allen,   I.R.    Abbott, 
D.C. Miller, J. Fidel and F.J. Epstein, 1994. 
Cervicomedullary tumors in children: A distinct 
subset      of      brainstem      gliomas.    Neurol., 
44: 1798-803. 
61.  Rubin, G., S. Michowitz, G. Horev, Z. Herscovici, 
I.J. Cohen, A. Shuper and Z.H. Rappaport, 1998. 
Pediatric brain stem gliomas: An update. Child. 
Nerv. Syst., 4: 167-173. 
62. Sheridan,  F.,  D. Scharf, V.W. Henderson and 
C.A. Miller, 1990. Lipomas of the mesencephalic 
tectum and rostral pons associated with sleep apnea 
syndrome. Clin. Neuropathol., 9: 152-156. 
63. Stroink,   A.R.,   H.J. Hoffman, E.B. Hendrick, 
R.P. Humphreys and G. Davidson, 1987. 
Transependymal benign dorsally exophytic brain 
stem gliomas in childhood: diagnosis and treatment 
recommendations. Neurosurgery, 20: 439-444. 
65.  Tomita, T., D.G. McLone and T.P. Naidich, 1984. 
Brain stem gliomas in childhood. Rational 
approach     and      treatment.    J.      Neurooncol., 
2: 117-122. 
66. Vandertop,   W.P.,   H.J. Hoffman, J.M. Drake, 
R.P. Humphreys, J.T. Rutka, D.C. Amstrong and 
L.E. Becker, 1992. Focal midbrain tumors in 
children. Neurosurgery, 31: 186-194. 
66. Villani, R., S.M. Gaini and G. Tomei, 1975. 
Follow-up study of brain stem tumors in children. 
Child Brain, 1: 126-135. 
67. Walker, D.A., J.A. Punt and M. Sokal, 1999. 
Clinical management of brain stem glioma. 
Arch. Dis. Child., 80: 558-564.  